‘Non-Medical Switching’ Claim Riles Europe’s Biosimilars Industry

 
• By Ian Schofield
  
European countries
Two patient groups have concerns about "non-medical switching" of biosimilars in Europe
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics